These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3153612)

  • 21. Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics.
    Murphy BR; Collins PL
    J Clin Invest; 2002 Jul; 110(1):21-7. PubMed ID: 12093883
    [No Abstract]   [Full Text] [Related]  

  • 22. Prospects for hepatitis C vaccine.
    Bhopale GM; Nanda RK
    Acta Virol; 2004; 48(4):215-21. PubMed ID: 15745044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are animal retroviruses potential candidates for an AIDS vaccine?
    Di Guardo G
    Acta Virol; 1990 Sep; 34(5):495. PubMed ID: 1981462
    [No Abstract]   [Full Text] [Related]  

  • 24. The new generation of recombinant viral subunit vaccines.
    Ellis RW
    Curr Opin Biotechnol; 1996 Dec; 7(6):646-52. PubMed ID: 8939634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent developments in the biology of respiratory syncytial virus: are vaccines and new treatments just round the corner?
    Hussell T; Openshaw P
    Curr Opin Microbiol; 1999 Aug; 2(4):410-4. PubMed ID: 10458984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetically engineered viral vaccines--prospects for the future.
    Pettersson RF
    Ann Clin Res; 1982 Dec; 14(5-6):245-52. PubMed ID: 6763495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prospects and achievements of genetic engineering in development of antiviral vaccines].
    Tikhonenko TI
    Mol Biol (Mosk); 1984; 18(1):176-88. PubMed ID: 6323971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The prospects for the development of viral vaccines].
    Bektimirov TA; Gorbunov MA
    Voen Med Zh; 1995 Jul; (7):45-8. PubMed ID: 7571512
    [No Abstract]   [Full Text] [Related]  

  • 29. Viral vaccines and antivirals: current use and future prospects.
    Parkman PD; Hopps HE
    Annu Rev Public Health; 1988; 9():203-21. PubMed ID: 3288231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants.
    Karron RA; Wright PF; Belshe RB; Thumar B; Casey R; Newman F; Polack FP; Randolph VB; Deatly A; Hackell J; Gruber W; Murphy BR; Collins PL
    J Infect Dis; 2005 Apr; 191(7):1093-104. PubMed ID: 15747245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccines and immunotherapies against hepatitis B and hepatitis C viruses.
    Inchauspé G; Michel ML
    J Viral Hepat; 2007 Nov; 14 Suppl 1():97-103. PubMed ID: 17958650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The future of vaccines: recombinant DNA vaccines].
    van Dam RH; Keus RJ
    Tijdschr Diergeneeskd; 1990 May; 115(9):413-9. PubMed ID: 2188394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant yeast hepatitis B vaccine.
    Hilleman MR
    Dev Biol Stand; 1986; 63():57-62. PubMed ID: 3527821
    [No Abstract]   [Full Text] [Related]  

  • 34. [Etiology, diagnosis and the prospects for vaccinal prevention hepatitis B].
    Anan'ev VA
    Vestn Akad Med Nauk SSSR; 1983; (12):37-40. PubMed ID: 6229935
    [No Abstract]   [Full Text] [Related]  

  • 35. The development of a vaccine against hepatitis B.
    Krugman S
    Scand J Infect Dis Suppl; 1983; 38():9-12. PubMed ID: 6580728
    [No Abstract]   [Full Text] [Related]  

  • 36. The iscom antigen-presenting system.
    Morein B
    Nature; 1988 Mar; 332(6161):287-8. PubMed ID: 3347272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In this issue: shifting the focus to modern vaccinology.
    Bot A
    Int Rev Immunol; 2009; 28(1):1-3. PubMed ID: 19241249
    [No Abstract]   [Full Text] [Related]  

  • 38. Recombinant polioviruses as candidate strains of oral poliovaccines.
    Nomoto A
    Dev Biol Stand; 1995; 84():123-7. PubMed ID: 7796944
    [No Abstract]   [Full Text] [Related]  

  • 39. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
    HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccines in historic evolution and perspective: a narrative of vaccine discoveries.
    Hilleman MR
    J Hum Virol; 2000; 3(2):63-76. PubMed ID: 10850891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.